Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
The Conference on the Future of Europe is your chance to share your ideas and shape the future of Europe. Make your voice heard!
Belgium-Brussels: Purchase, storage and delivery of live attenuated vaccine against lumpy skin disease
Section I: Contracting authority
Section II: Object
Purchase, storage and delivery of live attenuated vaccine against lumpy skin disease.
The Commission intends to maintain a stock of live attenuated LSD vaccine in storage in order to make it rapidly available in case it is needed. In addition, this stock of live attenuated vaccine should be replaced quickly, when depleted, in order to maintain the Union's capability to respond to an emergency.
See Internet address provided in Section I.3.
The duration of the contract is 48 months after the signature of the contract by the last contracting party, extended with the remaining shelf life of the vaccines in stock at the end of this initial contract duration.
Section III: Legal, economic, financial and technical information
Section IV: Procedure
The recent increase of LSD outbreaks in Greece and Bulgaria and the fact that LSD without proper control tends to spread unexpectedly over long distances mainly due to movements of animals, and over mid-distances exclusively due to vectors activity, makes that other Member States such as Romania are at direct risk too. Additional support in the form of LSD vaccines is also needed for the former Yugoslav Republic of Macedonia to prevent further spread to other EU Member States.
The urgency of the situation renders the normal time limits for open procedures impracticable because vaccines must be administered before the end of the summer.
rue Breydel 4 — B232 6/17A, 1040 Brussels, BELGIUM.
Section VI: Complementary information